ADVB - Company ID 0001941029
The table below shows Advanced Biomed Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue | $127.64K | - | - |
| Cost of revenue | - | - | - |
| Gross profit | - | - | - |
| R&D | - | $909.77K | $880.19K |
| SG&A | $4.63M | $2.11M | $1.66M |
| Operating income | -$6.23M | -$1.09M | - |
| Income tax | -$1.21K | - | - |
| Net income | $6.68M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$3.26M |
| -$2.78M |
| EPS (diluted) | $5.33 | -$0.16 | -$0.14 |